Praeter legem

Novartis launches "Meet The PROS" to raise awareness and support education for PIK3CA-Related Overgrowth Spectrum (PROS)

Retrieved on: 
Tuesday, August 31, 2021

Through theMeet The PROSinitiative, we aim to answer the community's call for more awareness and educational resources," said Reshema Kemps-Polanco, Head of Novartis Oncology, US.

Key Points: 
  • Through theMeet The PROSinitiative, we aim to answer the community's call for more awareness and educational resources," said Reshema Kemps-Polanco, Head of Novartis Oncology, US.
  • "I'm hopeful that these resources will help parents and families learn more, feel less alone and raise awareness about the physical and emotional impacts of these rare conditions."
  • "It's great to have additional resources, created by and for the community, to help raise awareness and education about PROS."
  • Located in East Hanover, NJ, Novartis Pharmaceuticals Corporation an affiliate of Novartis is reimagining medicine to improve and extend people's lives.